首页 › 直肠癌 › 犹他州 › Salt Lake City
Salt Lake City UT 直肠癌临床试验
8项针对 直肠癌的研究正在 Salt Lake City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
招募中观察性研究
- Utah Cancer Specialists, Salt Lake City
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
招募中
- George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
ColoSeal™ ICD System Anastomotic Protection Pivotal Study
招募中
- University of Utah Health, Salt Lake City
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
招募中1 期
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
招募中2 期
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
招募中
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Improving Care for Rural Patients With Solid Tumors
招募中
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Salt Lake City
其他城市的 直肠癌试验
- New York City, NY17 项研究
- Boston, MA12 项研究
- Houston, TX11 项研究
- St. Louis, MO11 项研究
- Columbus, OH10 项研究
- Los Angeles, CA10 项研究
- Tampa, FL9 项研究
- Nashville, TN9 项研究
- Seattle, WA9 项研究
- Baldwin Park, CA8 项研究
- Aurora, CO8 项研究
- Philadelphia, PA8 项研究
Salt Lake City的其他研究
- 非小细胞肺癌31 项研究
- 癌症（所有类型）27 项研究
- 乳腺癌27 项研究
- 结直肠癌22 项研究
- 肺癌21 项研究
- 黑色素瘤21 项研究
- 多发性骨髓瘤21 项研究
- 转移性癌症20 项研究
- 卵巢癌19 项研究
- 肥胖症18 项研究
- 急性髓系白血病17 项研究
- 心力衰竭17 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。